A Family Story of AHP
This video was created for UK and Irish audiences. Featuring the story of a family living with AHP, their journey, perspective on genetic testing and living with a hereditary condition, their information needs and how they feel about the future. NP-UK-00187
▶︎
Rosaline, living with Hereditary ATTR (hATTR) amyloidosis
▶︎
Alnylam Act - No Charge, Third Party Genetic Testing & Counseling
▶︎
Alnylam & RNAi Therapeutics: Making our Medicines
▶︎
Mary (USA) – Living with Acute Intermittent Porphyria
▶︎
Alnylam Challengers: Improving Access to Healthcare in Boston by Investing in Care Navigators
▶︎
A Message from Alnylam CEO Yvonne Greenstreet - Reflecting on 2025 and Looking forward to 2026
▶︎
Alnylam's siRELIS(TM) Enzymatic Ligation Platform
▶︎
Alnylam & RNAi Therapeutics: Silencing Disease. Amplifying Life.
▶︎
Alnylam Announces $250 Million Expansion of U.S. RNAi Therapeutics Manufacturing Facility
▶︎
Physiopathologie de la PHA
▶︎
Alnylam & RNAi Therapeutics: Making our Medicines
▶︎
Marc – Living with Wild-Type ATTR Amyloidosis with Cardiomyopathy
▶︎
RNAi, a promising platform for drug development
▶︎